Based on these insights and the preliminary findings of this study, we hypothesize that alterations in CALU expression may affect PAAD cells’ ability to maintain endoplasmic reticulum homeostasis, potentially modulating the antitumor effects of BA. The gene discussed is CALU; the disease is pancreatic adenocarcinoma.